News & Events


Recent Firm Activities and Highlights

BC Platforms and Kaiser Permanente Win 2020 Microsoft Health Innovation Award for Precision Medicine Collaboration
05.19.20
BC Platforms and Kaiser Permanente today announced they are winners of the 2020 Microsoft Health Innovation Award in the Reimagine Health Category for enabling a unique way of pairing clinical and genomic data on the same platform to advance precision medicine capabilities. Read Full Release
2020 MedTech Breakthrough Awards Recognize COTA as the Best Overall Medical Data Solution Provider
05.18.20
Boston, MA – May 18, 2020 – COTA, Inc., a healthcare technology company that uses real-world data (RWD) to bring clarity to cancer care, is pleased to announce that MedTech Breakthrough has named COTA as a winner in the fourth annual MedTech Breakthrough Awards program for the “Best Overall Medical Data Solution Provider" award. The MedTech Breakthrough Awards recognize the top companies, people, platforms, and products in various industries including health, fitness, and medi Read Full Release
Forefront Telecare Launches Phase 2 of COVID-19 Response for Rural Hospitals
04.09.20
NASHVILLE, Tenn., April 9, 2020 (Newswire.com) - Forefront Telecare, Inc. (Forefront), the leader in providing behavioral telehealth to seniors and other vulnerable adults in rural communities across the United States, announced today the next phase of its #RuralHealthSTRONG COVID-19 Response Program. As part of this program, Forefront is offering behavioral telehealth carts with secure, HIPAA-compliant video conferencing at no-cost to hundreds of rural hospitals nationwide. This proven platform has already been deployed by Forefront to over 200 facilities across the country. Read Full Release
Introducing the BBJ’s Fast 50, The Region’s Fastest Growing Companies
04.08.20
The BosBizJournal has recognized COTA on its 2020 Fast 50 list! We are proud to be one of the fastest-growing private companies in MA this year & are committed to continuing on this path as we transform #cancer care. Congrats to all companies. https://bit.ly/2Xi1IlI #BBJFAST50 Read Full Release
Reveleer COVID-19 Business Continuity Update
04.01.20
Dear friends, As the world continues to rapidly change around us due to Coronavirus (COVID-19), we wanted to reach out to our partners, and prospective partners, to let you know what to expect from Reveleer during this challenging time.First and foremost, our thoughts go out to those who have been directly impacted by COVID-19 and those working on the front lines to treat and control the spread of illness.... Read Full Release
MedAptus Again Leads KLAS Mobile Charge Capture Rankings
02.04.20
The annual "Best in KLAS" report is out and for the tenth time since 2011, medaptus has earned a top ranking, this year in the Mobile Charge Capture category. The "2020 Best in KLAS Awards: Software & Services" names the top-performing healthcare IT and services companies based on customer feedback obtained in 2019. This latest award recognizes the performance of medaptus' charge capture technology which enables efficient, accurate, and complete coding and billing. Beyond the software's ability to "capture" a charge, a robust rules engine and interface gateway enable real-time charge management and reconciliation activities, regardless of charge source. This unique automation replaces manual processes with intelligence such as work queues that route charge data based on exception. This approach expedites the billing cycle and with less administrative effort.  Read Full Release
COTA Genomic Profiling Study Released
12.11.19
A retrospective review of the COTA Real World Data (RWD) database was performed to identify patients with pathologically confirmed metastatic colon cancer (mCC) diagnosed between January 1, 2013 and December 1, 2017. Although guidelines recommend molecular testing for patients with mCRC, the current study included patients with mCC and excluded rectal cancer cases. At the time of data extraction, the COTA database included demographic, diagnostic, treatment, and quality-of-care information for patients with colon cancer abstracted from the electronic health records from 23 practices including 258 oncologists in Arkansas, Maryland, Michigan, New Jersey, New York, and Tennessee who contribute data under Business Associate Agreements. All data were de-identified to be compliant with Health Insurance Portability and Accountability Act and Office of Health Promotion Research regulations for purposes of secondary research use. The structure of the COTA database has been reviewed by the Western Institutional Review Board and has been deemed exempt from patient informed consent. Read Full Release
Boston Millennia Parters
TUCK STUDENTS “VENTURE” TO BOSTON
12.10.19
Thanks to the initiative of Center for Private Equity and Venture Capital Executive Director, Jim Feuille D’79, who called everyone to attention from the dining booth seat, Brodie Stone T’20 and Ross Klosterman T’20 pitched their company, UnifiHealth, which is focusing on reimagining health benefits for small businesses. After an evening of socializing, we had a full Friday of scheduled stops at Bain Capital Ventures, Boston Millennia Partners, Charles River Ventures, Openview Venture Partners, Flare Capital, and Green D Ventures. Read Full Release
COTA
COTA, Inc. Announces Headquarter Relocation to Boston for Continued Growth
08.01.19
COTA, Inc., a healthcare technology company that uses real-world evidence to bring clarity to cancer care, has announced that the Company’s headquarters will be relocating to Boston on August 1, 2019. The Company will maintain a New York City presence, but will continue to grow and reinforce its operational activities in Boston. Boston’s robust health technology and life science industries fit perfectly with COTA’s mission of improving cancer care. The Company will be located at 101 Arch Street Read Full Release
Boston Millennia Parters
COTA Welcomes Daniel Lane as Vice President for HEOR to Drive Outcomes-Based Research in Oncology
07.25.19
COTA, Inc., a leading precision medicine technology company that uses real-world data to bring clarity to cancer care, has named Daniel Lane as its new Vice President for Health Economics and Outcomes Research (HEOR). Daniel brings extensive experience in leading oncology outcomes research organizations, and leveraging innovative datasets to generate impactful real world evidence (RWE) across multiple healthcare sectors. Combining this with COTA’s expertise and understanding of real-world data will allow the company to better support its partners as they improve access and quality in healthcare. Read Full Release